Herpes zoster, inactivated vaccine (2027)
Complete · United Kingdom
Source: Find a Tender Service (UK)
The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JC
- Status
- Closed
- Location
- United Kingdom
- Updated
- 3 Nov 2026
- Source
- Find a Tender Service (UK)
ConstructChat
Ask ConstructChat about Herpes zoster, inactivated vaccine (2027)
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | complete |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice. |
Location
Country | United Kingdom (UK) |
Source
Source | Find a Tender Service (UK) |
URL |
More Details
Record type | Tender |
Article published date | 2026-09-21 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
